Global Nucleic Acid Amplification Testing Market Report and Forecast 2024-2032

Global Nucleic Acid Amplification Testing Market Size

The global nucleic acid amplification testing market attained a value of about USD 5.52 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 8.87% to reach nearly USD 11.21 billion by 2032. The growth is driven by the expansion of diagnostic applications in oncology and genetic testing across the globe.

Global Nucleic Acid Amplification Testing Market Outlook

• The rising application of nucleic acid amplification testing in higher research and development of drugs and disease diagnosis is boosting the market demand.

• In March 2023, Bio-Rad iQ-Check Real-Time PCR Kits received AOAC INTERNATIONAL and AFNOR approval to be used alongside CFX Opus Deepwell Real-Time PCR System, to enhance the product’s ability to find pathogens and its DNA. Such technical advancements are expected to enhance the market value in the forecast period.

• North America is expected to lead the market share in the forecast period. The market growth can be attributed to the presence of a well-developed infrastructure, focused on providing early diagnosis of severe diseases.

Global Nucleic Acid Amplification Testing Market Overview

Nucleic acid amplification testing is a molecular diagnostic technique used to detect DNA or RNA in a sample from the human body leading to accurate diagnoses of diseases. The sample may include blood, urine, or tissue. Nucleic acid amplification is highly sensitive and precise. It is a vital component of sample preparation, used for testing viruses or pathogens in patient samples making it a fundamental element in healthcare. It pinpoints the disease from diagnosis, leading to an effective treatment process.

Nucleic acid amplification testing is used to diagnose many ailments, including malaria, HIV/AIDS, TB, COVID-19, STDs, and respiratory tract infections (RTIs). Techniques like PCR are commonly used in diagnosis, making it possible to see the target nucleic acid even in tiny amounts. It also improves the accuracy of diagnosis.

Global Nucleic Acid Amplification Testing Market Growth Drivers

Rising Prevalence of HIV Cases Drive the Market Growth

The market for nucleic acid amplification testing is expected to witness growth, owing to the increasing cases of human immunodeficiency virus (HIV) across the globe. Nucleic acid amplification testing is used to screen for RNA or DNA strands. The strands are specific to the human immunodeficiency virus, which attacks immune cells. Most people get HIV involuntarily, through contact with the affected person's body fluids. It can also get transmitted through sexual contact or by using contaminated syringes. The World Health Organization (WHO) reports that around 39 million people worldwide had HIV. Awareness and use by sexually active people have driven historical growth. The availability of NAAT kits has enhanced market development recently.

COVID-19 Outbreak Elevated the Nucleic Acid Amplification Testing Market Demand Significantly

COVID-19 caused a significant hike in nucleic acid amplification testing worldwide. The sudden outbreak created a high demand for instant and accurate tests along with high-throughput testing. This led to a surge in nucleic acid amplification procedures, including PCR tests. These changes have made NAAT technology more available and credible. They applications are expected to grow beyond the pandemic as well, driven by the emphasis on infectious disease presentation and pandemic preparedness.

Advancements in Genetic Testing Likely to Boost the Market Growth

Nucleic acid amplification testing (NAAT) techniques are expanding into genetic testing as well. It offers precise, faster, and more efficient. This has led to improvements in the diagnosis of genetic ailments. Early detection of genetic diseases can lead to precise treatment, shaped on a patient’s genes. Modern genetic testing is also being conducted for multiple purposes. It can include prenatal diagnosis, which is exclusively tailored for inherited conditions during fetal development. Pharmacogenomics, which selects proper medications for patients based on their genetics is also employing nucleic acid amplification testing (NAAT) techniques. This is mainly because of the growing need for such genetic analysis. The increasing use of such technologies is projected to boost the market value in coming years. Moreover, surge in investments, fundings and infrastructure enhancements to promote medical research and development is expected to become a major catalyst in the market growth in coming years.

Global Nucleic Acid Amplification Testing Market Trends

Recent Developments in the Global Nucleic Acid Amplification Testing Market

In March 2023, Bio-Rad iQ-Check Real-Time PCR Kits received AOAC INTERNATIONAL and AFNOR approval. Designed to be used in combination with the CFX Opus Deepwell Real-Time PCR System, it enhances the product’s ability to find pathogens and its DNA. The CFX Opus Deepwell System integrates new real-time PCR technology and is designed for operational excellence in healthcare facilities. Being more compatible with iQ-Check kits, Bio-Rad can increase test use, boosting the outlook for in-vitro diagnostics sigificantly.

In May 2022, Meridian Bioscience, Inc., expanded its isothermal amplification product line by adding two new master mixes, namely, Lyo-Ready Direct DNA LAMP Saliva Mix and Lyo-Ready Direct RNA/DNA LAMP Saliva Mix. Both products use isothermal amplification. Meridian’s new master mixes refine the sensitivity and selectivity, helping in the detection of nucleic acids in saliva. With sudden COVID-19 outbreak, the demand for this technology has risen, especially in point-of-care molecular diagnosis. These methods have several merits, such as giving faster results.

In Sept 2022 - Mylab Discovery Solutions introduced the PathoDetect HPV detection tests to ascertain high-risk HPV strains in patients. This test recommended by the regulatory authorities, isolated two HPV types, which are linked to most cervical cancer types. Based on diagnostic technology that detects and differentiates high-risk HPV strains with high sensitivity and specificity in clinical samples, this test led to early detection of high-risk human papilloma virus (HPV) types.

Global Nucleic Acid Amplification Testing Market Segmentation

Market Breakup by Technique

• Polymerase Chain Reaction (PCR)

• Transcription-Mediated Amplification (TMA)

• Loop-Mediated Isothermal Amplification (LAMP)

• Nucleic Acid Sequence-Based Amplification (NASBA)

• Others

Market Breakup by Application

• Infectious Disease Diagnosis

• Cancer Diseases

• Genetic Testing

• Blood Screening

• Others

Market Breakup by End User

• Hospitals

• Diagnostic Laboratories

• Research Institutes

• Pharmaceutical and Biotechnology Companies

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Nucleic Acid Amplification Testing Market Share

Market Segmentation Based on Technique Poised for Growth

The market segmentation based on technique, includes polymerase chain reaction (PCR), transcription-mediated amplification (YMA), loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), and others. Among this polymerase chain reaction (PCR) is leading the market. This is due to innovations in molecular diagnostics. It has exceptional sensitivity and specificity in finding DNA and RNA, leading to more accurate results. It speeds up workflows and enables fast disease identification.

Market Breakdown by Applications Set to Drive Nucleic Acid Amplification Testing Market Growth

The market report also offers an insight into market breakup based on applications. It is segmented into infectious diseases, cancer, genetic testing, blood screening, and others. Among these applications, the infectious diseases segment is expected to dominate the market in the forecast period. This market value is mainly spurred by the urgent need to identify infectious agents in real-time, especially after the COVID-19 pandemic. With NAAT’s sensitivity and specificity, it is quite effective in diagnosing many infections, including new viruses like HIV and hepatitis and other unknown diseases. Cancer diagnosis is another major segment, likely to hold a significant market value in coming years. Nucleic acid amplification testing can help in finding genetic mutations and relevant biomarkers. These are crucial for early diagnosis and care plans. Another key segment is genetic testing with many applications, including prenatal testing and finding inherited diseases. Blood screening segment also demands NAAT application as it detects pathogens precisely in the blood stream.

Market Breakup by End Users to Boost Market Growth

The market segmentation based on end users includes hospitals, diagnostic laboratories, research institutes as well as pharmaceutical and biotechnology companies. Diagnostic laboratories are projected to hold a substantial market share in the forecast period. It plays a critical role in conducting many genetic tests and use advanced NAAT technologies. Research institutes also hold a significant market value, driven by high application of nucleic acid amplification testing technology in studies, drug development, genetic research, and pharmacogenomics.

Global Nucleic Acid Amplification Testing Market Analysis by Region

North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa are included in the regional market analysis. Among these, North America is expected to lead the market share in the forecast period. With a well-developed healthcare infrastructure, the region has elaborate labs and great diagnostic services. This infrastructure the adoption of superior technologies, resulting in aggressive research on technology innovations. Also, the increasing incidence of diseases like AIDS, hepatitis, and COVID-19 have increased the need for early and accurate detection methods, promoting market growth for NAATs. The presence of regulatory agencies, such as the Food and Drug Administration (FDA), ensure the quality of products and equipment. It plays a favourable role to bring new and innovative devices to the market.

Europe also has a substantial market value, driven by the presence of an effective healthcare system which promotes the use of advanced tests to identify diseases. Also, the presence of several research institutes and biotech companies in Europe offers a fertile ground for boosting the use of diagnostic technologies in the region.

Asia Pacific is likely to witness significant growth in the forecast period, driven by high demand for NAAT in the region. The demand is especially high in the Chinese and Indian markets, as these countries are meticulously investing into their healthcare systems. Rising incidence of infections, along with the growing understanding of the need for timely infection detection also adds to the high nucleic acid amplification testing market demand.

Latin America, the Middle East, and Africa are identified to have small market share. Growing spending on medical equipment and diagnostic centres is helping market growth. NAAT is witnessing high demand to improve public health and control the spread of diseases like HIV, tuberculosis, and malaria.

Leading Players in the Global Nucleic Acid Amplification Testing Market

The key features of the market report include strategic initiatives including partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Centre Testing International Group Co., Ltd.

Found in 2003, and based in Shenzhen, the company provides testing, inspection, and certification services for many industries. It emphasizes on guaranteeing quality and compliance.

SYNGENE INTERNATIONAL LIMITED

It is a global contract research organization based in Bangalore, India. It was founded in 1993 and provides a range of services in drug discovery and development. Syngene’s niche is offering more evidence on services for pharmaceutical organizations, while focusing on research and production.

NCIMB Ltd.

NCIMB was established in 1982, and is based in Aberdeen, Scotland. The organization offers services in microbial identification, preservation, and consulting. The products span across multiple domains including environmental, industrial, and healthcare.

Apollo Global Management, Inc.

Apollo Global Management was established in 1990 and is headquartered in New York. Apollo invests in many sectors of the economy, including health and technology. The technology sector owns stakes in firms that develop NAAT technologies through their investments.

Other companies in the market include Vitality Urgent Care and Max Lab Limited.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Key Questions Answered in the Nucleic Acid Amplification Testing Market

• What was the global nucleic acid amplification testing market value in 2023?
• What is the global nucleic acid amplification testing market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What are the major factors aiding the global nucleic acid amplification testing market demand? 
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• What are the major global nucleic acid amplification testing market trends?
• How does the rise in the geriatric population impact the market size?
• Who are the key players involved in the nucleic acid amplification testing market?
• What are the current unmet needs and challenges in the market?
• What is the market segmentation based on techniques?
• What is the market breakup based on application?
• Who are the major end users of nucleic acid amplification testing?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
• How is PCR technology driving growth in the nucleic acid amplification testing market?
• What advancements in PCR technology are enhancing diagnostic capabilities?
• What are the key applications of LAMP technology in clinical diagnostics?
• What are the emerging applications of NASBA in genetic testing?
• Which infectious diseases are predominantly diagnosed using the nucleic acid amplification testing market?
• How does nucleic acid amplification testing contribute to the rapid diagnosis of emerging infectious diseases?
• How is the nucleic acid amplification testing being utilized in cancer diagnostics and personalized medicine?
• How are hospitals integrating the nucleic acid amplification testing into routine diagnostic workflows?
• How are pharmaceutical companies leveraging the nucleic acid amplification testing in drug development?
• What factors are driving the growth of the nucleic acid amplification testing market in North America?
• How does the competitive landscape of the nucleic acid amplification testing market differ in Europe compared to other regions?
• What are the unique market dynamics influencing nucleic acid amplification testing market adoption in the Middle East and Africa regions?